News for hackers. Stuff that matters.

A comment on New HIV vaccine with a 97% antibody response rate in phase I human trials. Parent comment

Re:New HIV vaccine with a 97% antibody response rate in phas... by ceejayoz on Sunday April 04, 2021 @07:57PM (#26693907)
Successfully limiting the number of generic competitors still helps quite a bit.
[ Parent | on HN ]
Re:New HIV vaccine with a 97% antibody response rate in phas... by refurb on Sunday April 04, 2021 @10:33PM (#26694744)
That's not how the system works. The first generic get 6 months of market exclusivity. The FDA won't approve any other until after the 6 months is up.

And if one generic manufacturer was able to get approved, then the flood gates are open. It won't limit anything if all those additional patents were found invalid (which they would need to be for the 1st generic to be approved).

[ Parent | on HN ]
Re:New HIV vaccine with a 97% antibody response rate in phas... by ceejayoz on Sunday April 04, 2021 @10:49PM (#26694813)
I cited two specific ways used to keep “the flood gates” closed.
[ Parent | on HN ]
Re:New HIV vaccine with a 97% antibody response rate in phas... by refurb on Monday April 05, 2021 @02:52AM (#26696053)
Right, which don't apply to this situation.
[ Parent | on HN ]